EffRx - Ownership and Business Overview

Life ScienceCompany

EffRx Ownership

Who owns EffRx?

EffRx is owned by Abiogen Pharma. It was acquired on May 29, 2023.

EffRx Business Overview

Where is EffRx headquartered?

EffRx is headquartered in Freienbach, Switzerland.

What sector is EffRx in?

EffRx is a life science company.

When was EffRx founded?

EffRx was founded in 2010.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 197 acquisitions of life science companies in 2023, including 23 acquisitions by private equity firms, and 174 by strategics.

EffRx

EffRx Pharmaceuticals SA

Wolleraustrasse 41B,
Freienbach, 8807
Switzerland,
+41 44 503 78 60
www.effrx.com

EffRx develops and commercializes drugs, targeted in particular to musculoskeletal and rare diseases. The company's product range includes buffered soluble alendronate, a key agent from the class of bisphosphonates used in the treatment of osteoporosis. It licenses and distributes this drug under license agreements in 29 European and non-European countries. EffRx was founded in 2010 and is based in Freienbach, Switzerland.


 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.